CompanyGraph
What stands out
- Most companies in its industry are production businesses; this one is a sense-making business
At a glance
- Depends onUpstream position: supplies 6 industries, depends on 3
- ScaleMarket cap is $16.48M, lower than 95% of all stocks globally
- FinancialsAltman Z-Score -3.3: distress zone
- Interpretations3 currently firing — 3
What this company is and how it runs — written from structure, not news.
What stands out
- Most companies in its industry are production businesses; this one is a sense-making business
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
12.20MGBP16.48M · vs all stocks (USD)
Revenue (TTM)
1.60MGBP2.16M · vs all stocks (USD)
Profit Margin
-91.92%vs Biotechnology peers
Beta
1.22xvs all stocks
52-Week Change
-7.14%vs all stocks
Market Capitalization
12.20MGBP16.48M · vs all stocks (USD)
Enterprise Value
11.79MGBP15.92M · vs all stocks (USD)
Forward P/E
-10.83xvs Biotechnology peers
Price to Sales (TTM)
7.65xvs Biotechnology peers
Price to Book (MRQ)
16.25xvs Biotechnology peers
Enterprise to Revenue
7.38xvs Biotechnology peers
Enterprise to EBITDA
-8.43xvs Biotechnology peers
Profit Margin
-91.92%vs Biotechnology peers
Operating Margin
-64.44%vs Biotechnology peers
Return on Assets (TTM)
-55.09%vs Biotechnology peers
Return on Equity (TTM)
-164.37%vs Biotechnology peers
Revenue (TTM)
1.60MGBP2.16M · vs all stocks (USD)
Revenue per Share (TTM)
0.0150GBPUpdated Aug 1, 2026Quarterly Revenue Growth
-30.60%vs Biotechnology peers
Gross Profit (TTM)
352.00KGBP475.39K · vs all stocks (USD)
EBITDA (TTM)
-1.40MGBP-1.89M · vs all stocks (USD)
Net Income (TTM)
-1.47MGBP-1.98M · vs all stocks (USD)
Operating Cash Flow (TTM)
-1.18MGBP-1.59M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-776.88KGBP-1.05M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.00GBPUpdated Aug 1, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Biotechnology peers
Revenue
1.97MGBPFY2025 · Mar 31, 2025Cost of Goods Sold
1.53MGBPFY2025 · Mar 31, 2025Gross Profit
430.00KGBPFY2025 · Mar 31, 2025Operating Income
-1.78MGBP-2.40M · vs all stocks (USD)
Pre-tax Income
-1.78MGBPFY2025 · Mar 31, 2025Income Tax Expense
-64.00KGBPFY2025 · Mar 31, 2025Net Income
-1.71MGBPFY2025 · Mar 31, 2025EBIT
-1.77MGBPFY2025 · Mar 31, 2025EBITDA (Income Statement)
-1.67MGBPFY2025 · Mar 31, 2025Selling, General & Administrative
2.21MGBPFY2025 · Mar 31, 2025Non-operating Interest Income
5.00KGBPFY2025 · Mar 31, 2025Non-operating Interest Expense
3.00KGBPFY2025 · Mar 31, 2025EPS (Basic)
-0.0180GBPFY2025 · Mar 31, 2025EPS (Diluted)
-0.0180GBPFY2025 · Mar 31, 2025Basic Shares Outstanding
95.88MSharesFY2025 · Mar 31, 2025Diluted Shares Outstanding
95.88MSharesFY2025 · Mar 31, 2025Net Income from Continuing Operations
-1.71MGBPFY2025 · Mar 31, 2025Preferred Stock Dividends
0.00GBPFY2025 · Mar 31, 2025Operating Cash Flow
-1.56MGBPFY2025 · Mar 31, 2025Free Cash Flow
-1.57MGBPFY2025 · Mar 31, 2025Cash & Cash Equivalents (End of Period)
359.00KGBPFY2025 · Mar 31, 2025Starting Profit (CF Statement)
-1.71MGBPFY2025 · Mar 31, 2025Stock-based Compensation
35.00KGBPFY2025 · Mar 31, 2025Other Non-cash Items
-2.00KGBPFY2025 · Mar 31, 2025Change in Accounts Receivable (CF)
-75.00KGBPFY2025 · Mar 31, 2025Change in Other Assets/Liabilities
191.00KGBPFY2025 · Mar 31, 2025Capital Expenditures
-10.00KGBPFY2025 · Mar 31, 2025Net Investing Cash Flow
-10.00KGBPFY2025 · Mar 31, 2025Long-term Debt Payments
-23.00KGBPFY2025 · Mar 31, 2025Net Financing Cash Flow
532.00KGBPFY2025 · Mar 31, 2025Shares Outstanding
113.66MSharesUpdated Aug 1, 2026Float Shares
98.14MSharesUpdated Aug 1, 2026% Held by Insiders
12.37%vs all stocks
% Held by Institutions
26.36%vs all stocks
Total Cash (MRQ)
252.00KGBP340.33K · vs all stocks (USD)
Total Cash per Share (MRQ)
0.0020GBPUpdated Aug 1, 2026Total Debt (MRQ)
388.00KGBP524.01K · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.5344xvs Biotechnology peers
Current Ratio (MRQ)
1.80xvs Biotechnology peers
Book Value per Share (MRQ)
0.0060GBPUpdated Aug 1, 2026Total Assets
1.32MGBP1.79M · vs all stocks (USD)
Total Current Assets
1.26MGBPFY2025 · Mar 31, 2025Total Liabilities
654.00KGBPFY2025 · Mar 31, 2025Total Non-current Assets
63.00KGBPFY2025 · Mar 31, 2025Total Non-current Liabilities
31.00KGBPFY2025 · Mar 31, 2025Total Current Liabilities
623.00KGBPFY2025 · Mar 31, 2025Cash & Cash Equivalents
359.00KGBPFY2025 · Mar 31, 2025Accounts Receivable
332.00KGBPFY2025 · Mar 31, 2025Inventory
269.00KGBPFY2025 · Mar 31, 2025Accounts Payable
372.00KGBPFY2025 · Mar 31, 2025Short-term Debt
20.00KGBPFY2025 · Mar 31, 2025Long-term Debt
0.00GBPFY2025 · Mar 31, 2025Common Stock (Book)
4.20MGBPFY2025 · Mar 31, 2025Retained Earnings
-11.47MGBPFY2025 · Mar 31, 2025Total Shareholders' Equity
669.00KGBP903.50K · vs all stocks (USD)
52-Week Low
9.00GBXUpdated Aug 1, 202652-Week High
21.00GBXUpdated Aug 1, 202652-Week Change
-7.14%vs all stocks
Beta
1.22xvs all stocks
50-Day MA
11.75GBXUpdated Aug 1, 2026200-Day MA
13.27GBXUpdated Aug 1, 2026Avg 10-Day Volume
256.77KSharesUpdated Aug 1, 2026Avg 30-Day Volume
254.51KSharesUpdated Aug 1, 2026Diluted EPS (TTM)
-0.0100GBPUpdated Aug 1, 20263 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
High Machinery Share, High Accumulated Depreciation Share, And Elevated Sales-To-Non-Current-Assets
Machines are most of what it owns, mostly written off, and still producing plenty of sales.
Reads
Low Fixed-Asset Share With Elevated Turnover
It owns few buildings and machines, yet gets more sales and profit from its assets than its industry does.
Reads
Where is this company structurally exposed?
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
Most companies in its industry are production businesses; this one is a sense-making businessSignificant
Industry peers: 502Share on the common pattern %: 98.00
Looks liquid, but the distress score says otherwiseNotable
Current Ratio: 1.80Altman Z-Score: -3.30
Financial Health
Altman Z-Score -3.3: distress zoneCritical
Altman Z-Score: -3.30
Supply Chain
Upstream position: supplies 6 industries, depends on 3Notable
Outgoing: 6.00Incoming: 3.00
Scale
Market cap is $16.48M, lower than 95% of all stocks globallySignificant
Market cap (USD): 16,480,241.542Global P5: 269,387,740.27
Revenue is $2.16M, lower than 95% of all stocks globallySignificant
Revenue (USD): 2,155,445.88Global P5: 30,274,777.221
Companies that share the same coordination system — how they create, deliver, or capture value.
Ixico plc
Tier 1SenseMakingApproval-Gated PipelineProductionInterface
Hvivo Plc
Tier 1SenseMakingApproval-Gated PipelineProductionRule
Evotec SE
Tier 1SenseMakingApproval-Gated PipelineInterfaceProduction
Shanghai Medicilon Inc.
Tier 1SenseMakingApproval-Gated PipelineProduction
Caris Life Sciences, Inc.
Tier 1SenseMakingApproval-Gated PipelineProductionInterface
Fortrea Holdings Inc.
Tier 2SenseMakingApproval-Gated PipelineFlowInterface
Solvonis Therapeutics plc
Tier 3SenseMakingThroughput-Bound ConversionProductionRule
4Sight Holdings Ltd.
Tier 3SenseMakingExpertise LeverageProductionFlow
Malvern International Plc
Tier 3SenseMakingExpertise LeverageProductionInterface
Ondo Insurtech Plc
Tier 3SenseMakingThroughput-Bound ConversionProductionInterface
Companies that share active interpretations — structural patterns currently present in both stocks.
LG Innotek Co., Ltd.
2 interpretationsHigh Machinery Share, High Accumulated Depreciation Share, And Elevated Sales-To-Non-Current-AssetsUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Colgate-Palmolive (India) Ltd.
2 interpretationsLow Fixed-Asset Share With Elevated TurnoverHigh Machinery Share, High Accumulated Depreciation Share, And Elevated Sales-To-Non-Current-Assets
NHN KCP Corp.
2 interpretationsLow Fixed-Asset Share With Elevated TurnoverUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated